Local Funding Sources
Massachusetts Life Sciences Center
The Massachusetts Life Sciences Center (MLSC) is an investment agency that supports life sciences innovation, research, development and commercialization. The MLSC is charged with implementing a 10-year, $1-billion, state-funded investment initiative. These investments create jobs and support advances that improve health and well-being. The MLSC offers the nation’s most comprehensive set of incentives and collaborative programs targeted to the life sciences ecosystem. These programs propel the growth that has made Massachusetts the global leader in life sciences. The MLSC creates new models for collaboration and partners with organizations, both public and private, around the world to promote innovation in the life sciences.
Massachusetts Clean Energy Center
The Massachusetts Clean Energy Center (MassCEC) is dedicated to accelerating the success of clean energy technologies, companies and projects in Massachusetts—while creating high-quality jobs and long-term economic growth for the people of Massachusetts.
MassCEC provides early-stage investments to startup companies, funds renewable energy rebates for residents and businesses and supports the development of a local clean energy workforce. Since its inception in 2009, MassCEC has helped clean energy companies grow, supported municipal clean energy projects, and invested in residential and commercial renewable energy installations creating a robust marketplace for innovative clean technology companies and service providers.
MassVentures
MassVentures is a venture capital firm focused on fueling the Massachusetts innovation economy by funding early-stage, high-growth Massachusetts startups as they move from concept to commercialization. MassVentures focuses on Series A investments and considers occasional and opportunistic seed rounds. It provides capital for first-time CEOs and/or founders and consider industry segments not adequately served by the venture community.
SBIR/STTR Resource Center
The Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs are highly competitive programs that encourage domestic small businesses to engage in Federal Research/Research and Development (R/R&D) with the potential for commercialization. Through a competitive awards-based program, SBIR and STTR enable small businesses to explore their technological potential and provide the incentive to profit from its commercialization.
Pfizer Centers for Therapeutic Innovation
The Centers for Therapeutic Innovation (CTI) is a newly created entrepreneurial research unit at Pfizer. The center has established a collaboration with Boston University to translate novel biologic discoveries into testable clinical hypotheses leading to accelerated proof of mechanism in human subjects. Boston University faculty working on projects that may lead to new biologic therapies (i.e., proteins, antibodies, peptides, etc.) may apply for funding.
The Massachusetts Technology Collaborative
MTC is the state’s development agency for renewable energy and the innovation economy. MTC administers the John Adams Innovation Institute and the Renewable Energy Trust and works to stimulate economic activity in communities throughout the Commonwealth. Through the John Adams Innovation Institute and associated economic stimulus bills, MTC provides funding to support the creation of interdisciplinary research centers and to provide cost share to augment large federal research grants.
The NIBIB Center for Future Technologies in Cancer Care
CFTCC is focused on moving cancer treatments out of specialized centers and into local clinics or home care that could significantly lower healthcare costs. Often patients have to travel large distances to receive treatments at cancer centers. In low resource settings in the developing world, there may not be any options for cancer treatment. To address these issues, the Center is focusing on the identification, prototyping, and early clinical assessment of innovative point-of-care technologies for the treatment, screening, diagnosis, and monitoring of cancers. A major aspect of this effort involves assessing early-stage technologies in terms of clinical needs, market demands, setting appropriateness, and commercialization strategies. The integrated multidisciplinary team, consisting of engineers, clinicians, public health practitioners, and technology transfer experts, is currently evaluating technologies in various stages of development for suitability across a range of primary care and non-traditional healthcare settings. The Center comprises an Administrative Core, a Clinical Needs Assessment and Impact Analysis Core, a Training Core, and a Prototype Development and Testing Core divided into two parts, the Alpha and Beta Cores, which will both be available to Center projects, depending on the stage of technology development.